Upload
jasonsoung
View
735
Download
0
Embed Size (px)
DESCRIPTION
Self-introduction, including some basic info about hobbies etc, education background, and work experiences. Pharma, biotech, CRO, SMO, market research globally and in China.
Citation preview
Educ
atio
n
Educ
atio
nBasic
Info
Basic In
fo
Employm
ent
Employm
ent
山東省中國
諸城市
諸城市
around 30 years ago
姓:宋 (Song, Soo)名:傑 (Jie, Ketsu)Jason Soung
恐龙化石Dinosaur Fossil鸭嘴龙 -hadrosaur
Village elementary school: 5 years
Shandong University: 4 years
1st County high school: 3 years
Town junior high school: 4 years
Biology Olympics Contest
To be a MasterTo be a Master
Company
LOGO
Isolation and Identification of the Strains Producing Alginase, Purification, Characterization and Enzymatic Degradation of the ALY-SJ02 , Cloning and Expression of the Alginase Gene
Isolation and Identification of the Strains Producing Alginase, Purification, Characterization and Enzymatic Degradation of the ALY-SJ02 , Cloning and Expression of the Alginase Gene
Supervisor: Prof. Xiulan Chen Prof. Yuzhong Zhang
Supervisor: Prof. Xiulan Chen Prof. Yuzhong Zhang
Background
Alginates are synthesized as cell wall components by brown seaweeds and as exo-polysaccharides by two families of heterotrophic bacteria, Pseudomonadaceae and Azotobacteriaceae.
Alginate is widely used as a stabilizer, viscosifier, and gelling agent in the food and beverage, cosmetics, paper and printing, biomaterials, and pharmaceutical industries.
Background Alginate is an acidic linear polysaccharide
composed of (1→4)-linked α-L-guluronate (G) and its C5 epimer β-D-mannuronate (M); the uronic acids are arranged in three types of block structures, homopolymeric polyguluronate (PG), homopolymeric polymannuronate (PM), and heteropolymeric sequences of randomly distributed the residues (PMG), which are named G-blocks, M-blocks, and MG-blocks, respectively.
Alginates can be degraded by alginate lyases (alginases) which usually catalyze the cleavage of the glycosidic linkages via a β-elimination mechanism. Polysaccharide lyases are classified into 18 families (PL-1 to -18). Alginate lyases mainly occupy two families (PL-5 and -7).
Isolation & identification of the Strain
Optimization of
fermentation condition
Purification & characterizati
on of Alginase
Cloning & expression of Alginase geneSmall-scale
process development for
industrial utilization
Structure
Analysis
Program Flowchart
Engineering bacteria constructi
on
Strain SM0524 & ALY-SJ02
Impact Factor: 3.98
0524
-20
0
20
40
60
80
100
120
Rel
ativ
e ac
tivity
(%)
-0.4
0.1
0.6
1.1
1.6
2.1
2.6
OD
520/
680
相对酶活无用生物量降解度
opti mum te
mperature
0
20
40
60
80
100
120
2030
4050
6070
80
temperatur
e ℃rela
tive
act
ivit
y %y = 0. 3131x + 0. 096
R2 = 0. 998
0
0. 1
0. 2
0. 3
0. 4
0. 5
0. 6
0. 7
0. 8
0 1 2 31/ [S] ml / mg
1/v min/ug/ml
Km=3.2615mg/mlVmax=10.4167μg/ml/min
Heterogenous Expression
N-terminal sequence MALDI-TOF-MS
系统进化树→序列比对
TAIL-PCR
Expressed ALY-SJ 02
-20
0
20
40
60
80
100
120
20 30 40 50 60 70
Temperature(℃)Relative Activity(%)
Characterization of recombinant Alginase
Structure Analysis
-20
20
-10
0
10
190 250200 220 240
CD[mdeg]
Wavelength [nm]
Family PL-7
Process development Response Surface Method (RSM), 1951 年 , Box-Wilsong,
multiple factors, cross-interaction, limited time. Degrading Ratio : CCD: 3/3/17
Optimized Condition:
pH: 6.7
Time: 289min
Temperature: 38.8℃
Optimized Degrading Ratio:
71.35%± 0.02153
GenScipt
Presentation OverviewPresentation Overview
19
GenScript Overview1
GenScript Services2
GenScript Key Products3
GenScript Facilities4
Business Model5
Your Innovation Partner in Drug Discovery!
20
21Your Innovation Partner in Drug Discovery!
Your Innovation Partner in Drug Discovery!
GenScript At A Glance Founded in 2002 Over 1300 employees Headquarters in Piscataway, New Jersey USA Facilities and branches:
New Jersey, USA
Hub of big pharmasNanjing, China
Paris, France
Tokyo, Japan
22
New Nanjing Bio-Center
23Your Innovation Partner in Drug Discovery!
325,000 ft2
Capacity expansion: Gene : > 5,000 kb /month Protein : >300 batches / month Antibody: >300 orders/ month
Bioprocess: GLP grade Animal Facility
24
New Bio-Chemical Facility New Peptide Facility 30,000 ft2----200 Shimadzu HPLCs
Capacity expansion: Standard peptide: >6,000/month Pep library: ~50,000 peptides
/month Maintenance : >2,000 peptide
products
Your Innovation Partner in Drug Discovery!
25
Structure of Production
Your Innovation Partner in Drug Discovery!
Gene Synthesis — Any gene you desire!Largest Gene Supplier in US
Rush Gene, Rush Deliver!
Cloning —Any Cloing you want!
PCR Cloning/SubcloningKI & KO Vector ConstructionCustom vector construction
Mutagenesis — Any variant from your design!
Mutagenesis Library ConstructionTrimer Libraries
Plasmid Preparation — Any amount to fit your plan!Flexible Scale: 100 μg to 10,000 mg
Low Endotoxin Levels: <1 EU/mg
Molecular Biology Service
Largest Gene Synthesis Supplier !Your Innovation Partner in Drug Discovery! 26
Oligo synthesis —Any oligo you would like
Custom DNA and RNA oligoLargest oligo manufacturer in Asia
One-Stop Protein Services
Deliver Proteins with activityYour Innovation Partner in Drug Discovery!
Protein expression and purification services
Bacteria (Large-scale up to 1000 L )
Yeast(Large-scale up to 1000L)
Insect (Up gram Level){
* High-throughput Protein Variants ServiceGenerating & Selecting Protein Mutants?
GenScript Synthetic Biology Platforms
Up to 1,000 protein variants within 30 business days
*BacPowerTM Guaranteed Package Guarantee the amount of Protein: ≥ 3mg Guarantee the purity of protein: ≥ 75 or ≥85% purity Guarantee tag-free of protein Guarantee, or it’s FREE
Custom Peptide Synthesis Services
Standard Peptide SynthesisHigh complexity and purityLong peptides up to 200 aaHigh success rate ≥ 95%
Peptide Libraries Rapid parallel platformCompetitive prices Guaranteed deliveryFlexible screening tools
Cosmetic Peptides
Recombinant PeptidesFlexible technologyVariety of modifications Any length, any sequence, any scale
28
Leading the industry on peptide delivery success rate!
Your Innovation Partner in Drug Discovery!
Antibody Services
Your Innovation Partner in Drug Discovery!
Leading the industry on antibody guarantee!
29
30
Animal Facility
Total of 8,000 m2
SPF level for all rodent enclosures Application to
• Rodents (SPF)• Rabbits (Ab production)• Beagle dogs• Non-human primates (cynomolgus)• Individually Ventilated Cages (IVC)
System
Animal Facility
Your Innovation Partner in Drug Discovery!
Integrated and Seamless Bio-Assay Center
31Your Innovation Partner in Drug Discovery!
Given a target, we will delivery HTS-ready assay (w/ reagents)!
Bioprocess R&D
32Your Innovation Partner in Drug Discovery!
Antibody Drug Development CenterTarget Validation
Antigen Antigen ProductionProduction
Immuni-Immuni-zation zation // Hybridoma
Antibody Engineering
AffinityMaturation
AntibodyProduction
Target Selection
Preclinical Candidate
We Offer Integrated Services to Match Your Needs in Antibody Drug Development
Your Innovation Partner in Drug Discovery! 33
34Your Innovation Partner in Drug Discovery!
Animal Model Services
We offer comprehensive services to match your needs
eStain® 7-min Protein Staining System
35Your Innovation Partner in Drug Discovery!
Faster - complete protein gel staining in 7 minutes or less Easier - hit button and run Cleaner - no solutions and buffers required Safer - unique formulation without methanol
2nd Generation eStain® System
36Your Innovation Partner in Drug Discovery!
WuXi AppTec
We are determined to serve you betterWe are determined to serve you better
38
42
43
CRC Background & Projects Experience
44
EC Liaison & Site Initiation
Subject’s Visits Management
IMP Management
Study File Management
Clinical Sample Management
Safety Affairs
EDC/Data Entry
I. CRC Service
On-Site
Execution,
Coordination,
Management
Of Clinical Trials
Clinical Project Execution & Management
Investigator-Initiated Study
Phase IV/Post-Marketing study
Epidemiology study
Outcome Research
II. Study Management Service
45
Website Website
Community Community ActivitiesActivities
Disease EducationDisease Education
External ReferralExternal Referral
Recruitment Ad.
Internal Referral
Subject Database
III. Patients Education & Management
Subjects recruitment & referral
46
Broad Coverage across China
Henan
Hubei
Hunan
Ningxia
Tibet
Qinghai
Xinjiang
Gansu
Shanxi
Shaanxi
Yunnan
Guizhou
Sichuan
Guangdong
Hainan
Guangxi
Hong Kong
Hebei
Inner Mongolia
Shandong
Anhui
FujianJiangxi
Jiangsu
Zhejiang
Heilongjiang
Jilin
Liaoning
Chongqing
• 40 cities• 135 sites• 130 CRCs
2
2
52
4
5
2
28
1 3
315
64
23
4
5
42
1
3
4
7
3
4
2
2
1
1
Think…Learn…Think…Learn…
LINE/LinkedIn: JasonSoung
080-3680-0757